News
Stem cell transplants could be ‘transformational’ in type 1 diabetes
A second patient who received Vertex’s VX-880 has experienced glycemic improvements, while the first one is completely insulin independent.
News
Obesity in adolescence raises risk for adult type 1 diabetes
Risk of type 1 diabetes was doubled compared with adolescents with optimal body mass index in a study of military recruits.
News
ADA 2022 preview: Tirzepatide and much more
Full SURMOUNT-1 data, new approaches to type 2 diabetes management, discoveries in type 1 diabetes prevention and treatment, disparities, mental...
News
FDA clears Abbott Freestyle Libre 3 glucose sensor
New features on the Freestyle Libre 3 system include real-time readings, improved accuracy, and smaller size.
News
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Real-world study finds heart failure hospitalization reduction, compared with metformin but not MI, stroke, or overall mortality and with greater...
News
Vitamin D doesn’t reduce type 2 diabetes risk ... or does it?
“Given how prevalent prediabetes and type 2 diabetes are, clinicians and patients should consider vitamin D supplementation as an adjunct to...
News
Abaloparatide works in ‘ignored population’: Men with osteoporosis
Study finds increased bone mineral density from baseline to 1 year in men with osteoporosis.
News
First fatty liver guidelines for endocrinology, primary care
Endocrinologists and primary care docs “need to be the ones who are diagnosing and managing [non-alcoholic fatty liver disease] because there just...
News
Screening for diabetes at normal BMIs could cut racial disparities
Diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be ‘a good place to...
News
Undertreated hypothyroidism may worsen hospital outcomes
Large database study finds association between suboptimal hypothyroidism treatment and longer hospital stay, higher readmission rate.
News
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
The once-weekly investigational twincretin drug is in phase 3 development for obesity and under regulatory review, with a decision expected soon...
News
‘Profound implications’: COVID ups diabetes risk 40% a year later
‘All these roads are pointing in one direction, that COVID-19 increases the risk of diabetes up to a year later. If patients have a prior history...
News
Mild COVID-19 infection linked to later type 2 diabetes
Results point to the need to monitor blood glucose following SARS-CoV-2 infection.
News
Ukrainian diabetes care, insulin access ‘severely disrupted’
“I’m willing to see patients but it’s extremely difficult and dangerous for them and probably not possible to travel to see me.”